ArticleJournal of bone oncology2026

Corrigendum to "Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial" [J. Bone Oncol. 35 (2022) 100441].

Jiaji Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.